• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Safer injections targeted by new University of Bath project

Bioengineer by Bioengineer
March 23, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: University of Bath

Due to the complicated nature of preparing injections, mistakes are made in around a third of doses. Although these are often minor errors, it is a statistic that University of Bath pharmacist Dr Matthew Jones wants to change with a new project to improve patient safety.

Dr Jones has been awarded a National Institute for Health Research (NIHR) Transitional Research Fellowship to move from the laboratory into clinical research, as he seeks to makes injections and other medical procedures safer.

The little research completed so far suggests that about 35% of injections given in hospital include at least one error. Many of these mistakes will be minor and unlikely to harm the patient, but we don't know how many patients are harmed by injection errors. Dr Jones will see if changing the injected medicines guidance can reduce these problems, improve patient safety and possibly save the NHS time and money.

Dr Jones, who specialises in using evidence to help patients and professionals make good decisions, said: "People probably picture pharmacists behind a counter supplying medicines, but what we actually do most often is give advice, to patients and other medical professionals.

"Mistakes can be caused by unclear or ambiguous advice and patients can be harmed. There's lots of research about the best way to provide written information for patients but not about how professionals write for each other.

"I want to see if we can take techniques for improving patient information and apply that to information written by one professional for another professional."

He has chosen to work on the injected medicines guidance as injections are some of the most complicated types of medicine with a high error rate. The guidelines are typically written by pharmacists but used by nurses.

The first part of the two-year project will see 30 nurses giving feedback on existing guidance to modify it so they find it easier to follow and use. The document will evolve through several phases.

Then Dr Jones will take both the original and modified guidance into hospitals and ask hundreds of nurses in the middle of real shifts to perform injections on an artificial arm. They will be randomly allocated a version of the guidance and observed to see if they make any mistakes before being asked about their experience using the document.

The hope is that making the guidance better will cut down on mistakes, and could speed up the process of giving injections, both of which would be good for patients and the NHS.

Dr Jones said: "Making up an injectable medicine and then injecting it is a complicated, convoluted process. Most mistakes will be minor, but of course not all, and it's a risk. The injectable medicines guide is written by pharmacists, but used most often by nurses.

"We're trained in different ways, have different styles, sometimes we talk different professional languages and we need to cross that divide."

Alongside the experiments, Dr Jones will undertake work to model the potential economic benefits of cutting down on mistakes during injections, for example in reducing additional treatments or legal costs.

The two year fellowship will begin in January. During the project Dr Jones will collaborate with Professor Margaret Watson in the Department of Pharmacy & Pharmacology and colleagues the Universities of Leeds and Bristol, and UCL. If successful the findings could be used to inform changes to guidance for other kinds of medicine.

Dr Jones said: "It's a great opportunity to learn lots of new things and hopefully make a real difference to patient safety, I'm grateful to NIHR for the fellowship."

###

The NIHR Transitional Research Fellowship offers 18 – 24 months funding to support researchers to make a transition from basic or experimental science research to an area of applied health or clinical research which is within NIHR remit.

For further information, please contact Chris Melvin in the University of Bath Press Office on +44-0-1225-383-941 or [email protected]

Media Contact

Chris Melvin
[email protected]
44-012-253-83841
@uniofbath

http://www.bath.ac.uk

Original Source

http://www.bath.ac.uk/announcements/safer-injections-targeted-with-new-university-of-bath-project/

Share12Tweet8Share2ShareShareShare2

Related Posts

Fluorothiazinone Suppresses Burkholderia Lung Infection

April 1, 2026

YY1/Asprosin/PFKP Axis Drives Cardiac Hypertrophy

April 1, 2026

Lehigh University College of Health Launches HEAL Service Center: A Cutting-Edge Shared High-Resolution Mass Spectrometry Facility

April 1, 2026

NYU Abu Dhabi and University of Denver Scientists Discover Promising Small Molecule Inhibitor for Parkinson’s and Other Brain Disorders

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Author Corrects Study on Neck Training Effects

Fluorothiazinone Suppresses Burkholderia Lung Infection

Enabling Long-Haul 400G Optical Networks

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.